Actual Medicinal Product (AMP) Zidovudine 300mg / Lamivudine 150mg tablets (Viatris UK Healthcare Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Combivir 150mg/300mg tablets (ViiV Healthcare UK Ltd).

Generic
Zidovudine + Lamivudine
Formulation
Zidovudine 300mg / Lamivudine 150mg tablets
  • Zidovudine + Lamivudine
    • Zidovudine 300mg / Lamivudine 150mg tablets

      • Zidovudine 300mg / Lamivudine 150mg tablets (Viatris UK Healthcare Ltd)